Outcome of Board meeting held on 05.09.2025

Management Changes View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+4.1%Reaction day

₹35.00

prior close

₹36.45

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.0%+4.2% vs market

Healthcare Service Provider peers, median of 22sector-0.2%+4.3% vs sector

On the reaction day the stock moved 4.2 pts more than Nifty Microcap 250 and 4.3 pts more than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.0

15m

+0.0

30m

+0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+4.1-0.0+4.2-0.2+4.3

Next day

-1.4+0.4-1.9-0.1-1.3

-0.0+0.6-0.6-0.9+0.9

-5.4+1.0-6.5-1.1-4.3

-7.1+0.9-8.0-2.4-4.7

-4.4+0.8-5.3-3.2-1.2

-2.9+2.2-5.1+0.9-3.8

15d

-10.2-1.7-8.5-3.1-7.1

-10.9-0.5-10.3-3.8-7.1

-23.9-0.5-23.4-6.3-17.6

-0.7-4.7+4.0-12.0+11.3

UpDownMarket · Nifty Microcap 250Sector · Healthcare Service Provider peers, median of 22Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The board of Bandaram Pharma Packtech Limited met on 5 September 2025 and approved three key items. First, the re-appointment of Mr. Deepak Reddy Bandaram (DIN: 07074102) as Chairman and Managing Director for another 3-year term starting 7 February 2026, pending shareholder approval. Second, the board approved the Directors' Report for FY 2024-25 along with the notice for the upcoming Annual General Meeting. Third, the AGM has been scheduled for Monday, 29 September 2025 at 11:00 a.m., to be held via video conference. The meeting concluded at 11:45 a.m.

Likely market impact

Continuity at the top management level as the existing CMD gets another 3-year term, which provides leadership stability for shareholders. The upcoming AGM on 29 September will require shareholder approval for this re-appointment.